From: Advances in novel therapeutic approaches for periodontal diseases
Drugs | Polymer Type | Â | Outcomes | References |
---|---|---|---|---|
Metronidazole | Polycaprolactone (PCL) | Nanofiber | Effective local delivery system of metronidazole in combination with scaling and root planing showed betterment of clinical criteria, for example, plaque index (PI), pocket depth (PD), and gingival index (GI) | [158] |
Doxycycline | PCL | Controlled delivery of drug was able to improve PD, PI, and GI effectively in periodontal disease | [159] | |
Minocycline hydrochloride | Carbopol | Liposome | Liposomes containing minocycline hydrochloride showed biocompatibility along with improvement in rat periodontitis | [160] |
Minocycline hydrochloride | Poly Ethylene Glycol (PEG) | 2% minocycline hydrochloride nanoliposomes strongly inhibited TNF-α secretion by LPS-stimulated macrophages up to 60 h | [161] | |
Doxycycline | Carbopol | Slow release of drug from nanoliposome gel decreased MMP-8 in rat model of periodontitis | [162] | |
Metronidazole, Doxycycline | Polymersomes | Nanoparticle | Antibiotics encapsulated in polymersomes decreased the number of P. gingivalis in monolayer cells as well as in organotypic cultures significantly | [163] |
Metronidazole benzoate | Thiolated Chitosan (TCS)- Poly(methacrylic acid) (PMAA) | TCS-PMAA delivery system provided sustained and site-directed release of the drug. Also, the system led to an improvement in oral availability | [164] | |
Doxycycline | Chitosan | Pre-clinical studies showed that nanoparticles loaded with doxycycline showed entrapment efficacy of 75% and showed antimicrobial activity against P. gingivalis | [165] | |
Metronidazole | Chitosan | Microparticle | Hydrogel prepared from chitosan microparticles released metronidazole at an optimal pattern | [166] |
hydroxyapatite (HA) and Ofloxacin | Poly Lactic-Co-glycolic acid (PDLGA) | PDLGA microspheres were shown to be biocompatible and porous in nature. This system delivered the drug optimally against E. coli and S. aureus | [167] | |
Minocycline hydrochloride | Chitosan | Use of microsphere containing minocycline hydrochloride resulted in the decrease of PDs at 6Â months. In addition, bleeding on probing was also decreased significantly in patients | [168] | |
Doxycycline | Gelatin | Local delivery of antibiotics in the periodontal pocket along with scaling and root planing led to decrease in PDs. Moreover, the treatment method reduced the number of P. gingivalis significantly | [169] | |
Azithromycin | PLGA | Gel | Site-directed delivery of 0.5% of azithromycin showed better clinical output in periodontitis patients | [170] |
Metronidazole | Poly-gamma-glutamic acid | Hydrogel was prepared from a non-toxic and biodegradable material such as poly-gamma-glutamic acid. This hydrogel system could be polymerized by light and showed remarkable swelling ability along with a controlled manner of drug release | [171] | |
Clarithromycin | Carboxy methylcellulose | In adjunction with scaling and root planing treatment, local delivery of 0.5% clarithromycin showed better clinical outputs at 6Â months in smokers | [172] | |
Moxifloxacin | Pluronic Chitosan | Reduction in PD was observed in patients who received moxifloxacin gels at 3Â months. In addition, these gels were safe to use and significantly reduced the load of P. gingivalis among the periodontal pathogens Shows efficacy against A. actinomycetemcomitans | [173] | |
Chlorhexidine | Chitosan, beta-glycerophosphate | Nontoxic hydrogel system carrying 0.1% chlorhexidine effectively reduced the number of oral pathogens | [162] | |
Doxycycline | Hydroxyapatite | Scaffolds | Scaffolds loaded with doxycycline helps in the process of pre-osteoblasts of bone and tissue repairment in periodontal patients |